Proteases in cutaneous melanoma
- 1 January 1998
- journal article
- review article
- Published by Taylor & Francis in Annals of Medicine
- Vol. 30 (5) , 431-442
- https://doi.org/10.3109/07853899809002484
Abstract
From a great number of studies there is clear evidence that several extracellular proteolytic enzymes play an important role in various tumour-related processes. This review focusses on proteases in cutaneous melanoma. The current knowledge on and insights into the involvement of proteases in tumour progression are based on in vitro studies, on animal model studies and on investigations using patient material. In the field of melanoma, these three modalities are also applied to the investigation on the impact of proteases. Consequently, the current review summarizes research on both human melanoma cell lines and human melanocytic lesions. In addition, results obtained from animal experiments are included.Keywords
This publication has 57 references indexed in Scilit:
- uPA, uPAR, PAI-I: Key intersection of proteolytic, adhesive and chemotacfic highways?Immunology Today, 1997
- The plasminogen activation system in melanoma cell lines and in melanocytic lesionsMelanoma Research, 1996
- Biology of tumor cell invasion: Interplay of cell adhesion and matrix degradationInternational Journal of Cancer, 1996
- Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells.Journal of Clinical Investigation, 1995
- Clinical relevance of cathepsin B-like enzyme activity and cysteine proteinase inhibitor in melanocytic tumoursArchives of Dermatological Research, 1995
- Biochemical and immunohistochemical analysis of cathepsins B, H, L and D in human melanocytic tumoursArchives of Dermatological Research, 1995
- Inhibition of the metastatic spread and growth of B16‐BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitorInternational Journal of Cancer, 1994
- Differential regulation of gelatinase b and tissue‐type plasminogen activator expression in human bowes melanoma cellsInternational Journal of Cancer, 1993
- Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: A key event in melanoma cell invasiveness in vitroExperimental Cell Research, 1992
- Tissue inhibitor of metalloproteinase‐2 (TIMP‐2) has erythroid‐potentiating activityFEBS Letters, 1992